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Abstract
           Tachycardia induced cardiomyopathy (TIC) is defined as atrial or ventricular dysfunction 
as a result of prolonged elevated heart rate that is reversible upon control of the arrhythmia. 
There may be no underlying structural heart disease primarily responsible for the cardiac 
dysfunction. We present some examples of arrhythmias causing TIC and the resolution of the 
ventricular dysfunction following their appropriate management. Included in the review are also 
the pathophysiology, clinical spectrum, diagnosis and appropriate management of the condition.
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Introduction
            Tachycardia induced cardiomyopathy (TIC) occurs as a result of prolonged elevated heart 
rates and resolves with treatment of the arrhythmia1,2. Different arrhythmias have been reported 
to result in ventricular dysfunction. These include automatic atrial arrhythmias including ectopic 
atrial tachycardia, atrial fibrillation and re-entry atrial and atrioventricular arrhythmias such as 
atrial flutter3 and intra atrial re-entry tachycardia (IART) in congenital heart disease (CHD) and 
permanent junctional reciprocating tachycardia (PJRT)4 and incessant slow atrioventricular nodal 
tachycardia (AVNRT) and atrioventricular (AV) re-entry tachycardias5. Ventricular arrhythmias 
such as sustained ventricular tachycardia (VT)6 and premature ventricular contractions (PVC)7 
have also been reported to cause ventricular dilation and dysfunction. The diagnosis of TIC needs 
to considered when no other obvious explanation is forthcoming for cardiac dysfunction and is 
often retrospective as the patient improves clinically with rate and/or rhythm control. The 
prevalence is hard to estimate as it is mainly described in case reports. In some cases it may be 
difficult to determine whether the tachycardia is secondary to underlying cardiomyopathy or is 
playing a causative role (especially in arrhythmias such as atrial fibrillation8)                     
Case   report   1                                                                                      
            A 6 month old infant girl presents with a 5-6 day history of poor feeding and tachypnea. 
She looked pale and lethargic. Examination revealed elevated heart rate of 180 beats per minute 
(BPM) with gallop. EKG showed (Figure 1) narrow complex tachycardia with a long RP interval 
and negative P waves in leads II, III, and AVF  consistent  with  PJRT.  Echocardiogram  showed 
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depressed ventricular function with no structural abnormalities. Management included drug 
therapy with Flecanide and Sotalol with normalization of EKG and improvement in ventricular 
function   in   one   week.                                                                          
Figure 1: 6 month old with PJRT who has narrow complex tachycardia with long RP interval (260ms) 
and negative P waves in leads II, III, AVF.
Case   report   2                                                                         
              
            6 yr old boy presented to the emergency department with a 4-day history of fatigue. 
Evaluation revealed a pale child, 23kg, with a heart rate of 182 bpm. EKG revealed wide 
complex tachycardia (QRS 128ms, 181bpm) with VA dissociation (Figure 2), LBBB, and 
inferior QRS axis (45º). CXR showed cardiomegaly (Figure 3). Echocardiogram showed 
moderate to severe biventricular dysfunction with moderate mitral valve insufficiency. The 
fractional shortening was 15% with an ejection fraction of 28%. VT did not respond to 
intravenous (IV) lidocaine but converted to sinus rhythm with Procainamide bolus of 5mg/kg. 
Ventricular function improved and the patient was taken to the EP laboratory for a successful 
ablation of a right ventricular (RV) outflow tract focus.   
Pathophysiology
            Several pathological changes have been described but it remains unclear as to whether 
they play an etiologic role or they arise as a consequence of the tachycardia. Hemodynamic 
alterations include reduced cardiac output, biventricular dysfunction, elevated filling pressures 
and elevated systemic vascular resistance9. There is also associated neurohormonal activation 
characterized by elevated plasma atrial natriuretic peptide levels, high epinephrine and nor-
epinephrine concentration, increased renin and aldosterone activity10. The exact mechanisms are 
not well understood. Some of the changes that have been described in animal and human studies 
are as follows:
 
Myocardial ischemia and energy store depletion                                                       
            High energy myocardial stores have been shown to get depleted in animal models with 
persistent tachycardia. These include diminished Na-K-ATPase activity and lower  myocardial 
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levels of adenosine triphosphate (ATP), phosphocreatine and creatine11,12. They may result from 
increased activity of Krebs cycle enzymes and mitochondrial injury13. These changes have been 
reproducible and reversible in ischemic myocardial injury14. This may explain a cause-effect 
relationship between TIC and myocardial ischemia.                                                                 
Figure 2: 6 yr old with sustained RV outflow tract VT at a rate of 180 bpm. The EKG also shows VA 
dissociation. 
Figure 3: EKG showing ectopic atrial tachycardia (right atrial crista) at rate of 200 bpm. 
P waves are positive in lead I and AVF and negative in V1. 
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Abnormal receptor response and oxidative stress                                                                         
            There is decreased beta-adrenergic responsiveness15 and abnormal Calcium (Ca) channel 
activity and sarcoplasmic reticulum Ca response resulting in reduced cellular energy described in 
different animal models12,16. There may also be down regulation of myocyte beta-1 receptor 
density. Oxidative stress injury of the myocardium may result in accumulation of peroxynitrite 
and subsequent modification of myofibrillar proteins and energetics. This results in an imbalance 
of pro-oxidant and anti-oxidant pathways17.                                                               
Genetic basis / ACE gene polymorphism                                                                                           
            Elevated levels of angiotensin converting enzyme (ACE) are associated with deletion of 
the ACE gene (D). The DD (deletion) phenotype has been shown to be significantly more 
common in patients with TIC18  (they also have elevated serum ACE levels).                   
Histologic   Modifications                                                                                    
            The various histological changes associated with TIC include myocyte hyperplasia and 
lengthening19, myocardial fibrosis, impaired coronary reserve and apoptosis.                     
Clinical   Manifestation                                                                                      
            Clinical symptoms in children may be non specific with symptoms of shortness of breath, 
fatigue, exercise intolerance and palpitations. Infants often present with poor feeding and 
tachypnea. The risk of sudden death may be as high as 10 %20. Physical examination may reveal 
a tachycardia out of proportion to age with or without edema, poor skin perfusion, gallop rhythm 
and regurgitant murmurs from AV valve insufficiency. Other signs of CHF such as elevated 
jugular venous pulse, liver enlargement and basal rales may also be present.                          
Differential   Diagnosis                                                                  
            The diagnosis of TIC requires a high index of suspicion. Workup includes an EKG that 
may show the culprit arrhythmia responsible. Chest X-ray is helpful in confirming an enlarged 
cardiac   silhouette   and   increased   pulmonary   vascular   markings   indicating   elevated   filling 
pressures. Echocardiogram often reveals LV and LA dilation with diminished shortening and 
ejection fractions. There may be evidence of systolic and / or diastolic ventricular dysfunction. 
Differential diagnosis includes other causes of cardiomyopathy including dilated, infective and 
ischemic etiologies. Complete or partial recovery of cardiac function with rate or rhythm control 
favors   TIC.                                                                                                      
Arrhythmias causing TIC                                                                                     
            Almost all arrhythmias can cause TIC. Some of the common once are listed in Table 1.    
Supraventricular   arrhythmias                                                                          
            In newborns re-entry SVT is the commonest cause of TIC. Some ventricular dysfunction 
is almost universal as diagnosis is often delayed. SVT at higher rates is better tolerated in this age 
group and infants often present after days of onset of the arrhythmia21. Longer the duration of 
SVT, worse the cardiac function. The prognosis and recovery of cardiac function after control of 
SVT is excellent.
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Table 1: Arrhythmias causing tachycardiomyopathy
            Ectopic atrial tachycardia22 is probably the second most common cause of TIC especially 
in older children (Figure 3). They can arise from either the RA or LA. Most EATs have no 
specific etiology but infection has been suspected in some cases. Post operative (both acute and 
chronic) states have known to cause ectopic foci that can be responsible. Clinical spectrum is 
similar and the duration and the rate of the tachycardia determine the severity of TIC. 
Radiofrequency or cryo ablation is usually the treatment of choice in older children after initial 
supportive management of the cardiac dysfunction which may include diuretics (frusemide). 
Medical antiarrhythmia management with flecanide, procainamide, sotalol or amiodarone (or 
combination therapy) is usually successful.                                                                       
            PJRT is mediated by a slow retrograde conducting concealed accessory pathway which is 
usually located in the posteroseptal right atrium. The SVT has a typical long RP interval with 
negative P waves in leads II, III, and AVF (Figure 1). The SVT can be refractory to medical 
management. They respond well to ablative therapy4. Anti arrhythmic drug therapy may include 
various combinations of flecanide, sotalol and amiodarone.                                   
            Atrial flutter and intra-atrial re-entry tachycardia are more common in children with CHD 
who have had surgical interventions and subsequent atrial scarring. Multiple atrial re-entry 
circuits may be present and ablation with or without antiarrhythmic drug therapy may be 
effective.   Cardiac   dysfunction   is   usually   reversible   with   control   of   atrial   flutter3. 
Thromboembolic risk is also increased and has to be taken into consideration after diagnosis 
before treatment plans are formulated.                                                                                         
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            Postoperative junctional ectopic tachycardia (JET) has been seen with surgical repair of 
VSDs, tetralogy of Fallot and AV canal defects. The congenital form of JET occurs in non 
surgical cases and may be inherited23. These tachycardias gradually warm up and can cause 
cardiac dysfunction over a period of few hours after surgical intervention. Medical management 
includes appropriate timely recognition and use of antiarrhythmic agents such as amiodarone 
with control of body temperature. Congenital JET is rare but more difficult to recognize and 
treat. Multiple drugs may need to be used including amiodarone, sotalol and flecanide.  
            Atrial fibrillation is uncommon in children but a common cause of TIC in the adult 
population  and may depress cardiac function by 15-20%8.                                         
Ventricular   Arrhythmias                                                                      
               Both   non-sustained   and   sustained   ventricular   arrhythmia   can   result   in   cardiac 
dysfunction. Frequent RV outflow tract PVCs (LBBB morphology with inferior axis) has been 
described by authors6  with improvement of symptoms and function after successful ablative 
treatment. Sustained VTs such as bundle branch re-entry VTs are more common in structural 
heart disease (such as primary cardiomyopathy) and cause-effect relationship may be confusing. 
Other VTs such scar VTs (after CHD repair) and idiopathic LV VT may compromise ventricular 
function in the acute phase and improve after rhythm control. Ventricular pacing at fast rates has 
also been associated with depressed cardiac function.                                          
      
Prognosis
            The prognosis depends on the rate and duration of the arrhythmias which are two factors 
that influence severity of cardiac dysfunction. Younger children (especially newborns and 
infants) tend to make complete recovery. Recurrence of the arrhythmia after apparent resolution 
may be associated with precipitous decline in LV systolic function and rapid development of 
symptomatic heart failure20. Diagnosis of TIC may be difficult in some cases where the culprit 
arrhythmia is relatively slow and not incessant and may be retrospective with improvement of 
cardiac function after rate and/or rhythm control. Long term treatment may include diuretics 
(such as furesemide), ACE inhibitors, betablockers with adjunctive RF ablation or antiarrhythmic 
drugs. Improvement of ventricular function occurs as early as one week and complete resolution 
in   4-6   weeks.                                                                                
Conclusion
            The recognition of TIC with arrhythmias in children is important as appropriate treatment 
(rhythm and/or rate control) has a good outcome. TIC may be one the one of the most common 
unrecognized curable cause of heart failure that needs to taken into consideration in the 
differential diagnosis of idiopathic dilated cardiomyopathy.
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